We have thousands of scientists working for you.

Sign up to stay connected with all Thermo Scientific resources, applications, blog posts and promotions.
Keep Me Informed!
0225-Koomen-wp-feat
0225-Koomen-headshot

Dr. John Koomen on Data-Independent Analysis and Targeted MS/MS Quantification of Biomarkers

Clinical research applications of proteomics increasingly rely on MS-based approaches. Biomarker discovery, development, verification, validation, and quantification are all accessed using these approaches. Although different data collection modes exist for biomarker assessment, John Koomen, Associate Member and Scientific Director of Proteomics at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, focuses on the emerging DIA mode int his webinar review Combining Data-Independent Analysis (DIA) for Broad-Scale Phenotyping and Targeted Tandem Mass Spectrometry Quantification of Specific Biomarkers.

Technique: LC-MS Resource Type: White Paper
Register

Want to be the first to know?

Sign up to stay connected with all Thermo Scientific resources, applications, blog posts and promotions.
Sign up below:


Keep Me Informed!
By signing up you agree to our Customer Data Terms and Conditions.

By submitting my data, I agree that Thermo Fisher Scientific and its affiliates ("Thermo Fisher") managing the brands Life Technologies, Thermo Scientific, Unity Lab Services, Fisher Scientific may collect, process and use my data for advertising purposes relating to events, products, services and promotions. Therefore, Thermo Fisher may store my data in US hosted, group wide shared applications of third party vendors (e.g. Salesforce Inc., Oracle Inc.) acting on Thermo Fisher's behalf and receiving instruction in accordance with data privacy laws applicable and other applicable laws. You can withdraw your consent to this data processing at any time by e-mailing analyze@thermofisher.com.

Hide